AcquisitionSoftware
BIOREGENX, INC. acquired target
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
BIOREGENX, INC. -> target · $22,000
Endocalyx Pro , a dietary supplement targeting microvascular capillary health, has achieved remarkable monthly sales figures, demonstrating consistent growth.
Open source record (SEC) ↗